CV Science

Xavier Durrmeyer MD, PhD Clinical Epidemiology

Course and current status

Education

2017: Accreditation to supervise research, Créteil University, UPEC, France
2014: PhD in Clinical Epidemiology. UPMC, Paris, France
2003: Certification in Paediatrics, Doctor in Medicine, Paris Descartes University, France
2003: Masters in Respiratory Biology and Physiology, directed by Pr Delacourt, Créteil University, UPEC, France
2000: Certification in Cellular Pharmacology, Pharmacogenetics and Pharmacokinetics, Paris Descartes University, France
1993: Certification in General Biochemistry, Paris Descartes University, France

Carrier history

Since 2016: Associate researcher at Inserm U955, IMRB team 13, biomechanics and respiratory apparatus: a multi-scale approach 
Since 2014: Associate researcher at Inserm U 1153, EPOPé perinatal epidemiology research team
Since 2008: Consultant Neonatologist in Neonatal Intensive Care Unit, Dr Dassieu, Hôpital Intercommunal de Créteil, France
November 07 to October 08: Fellowship in Pediatric and Neonatal Intensive Care Unit, Pr Berner, Geneva, Switzerland
November 03 to October 07: Fellowship in Neonatal Intensive Care Unit, Dr Janaud, Hôpital Intercommunal de Créteil, France
November 02 to October 03: Research Student in a research laboratory, « Pulmonary Development Team » leader Dr J. Bourbon, Inserm U492 (now U651) directed by Pr Adnot, Créteil, Université Paris XII, France
November 96 to  October 02: Residency in Paediatrics in Paris, France

Scientific summary

Xavier Durrmeyer is a Neonatologist currently working in the Neonatal Intensive Care Unit in Créteil France, where he performed his fellowship. He was principal investigator for several multicenter trials and obtained a PhD in clinical Epidemiology in 2014. He is also an associate researcher affiliated to Inserm U 1153, EPOPé perinatal epidemiology research team.

His main research topics are:

- pain control in neonates requiring intensive care, especially during airway access (intubation);

- lung protection in neonates and prevention of bronchopulmonary dysplasia;

- assessment of clinical practices in Neonatology

He is a member of the steering committee for the french Epipage 2 national cohort study on premature infants.